Marathon Trading Investment Management LLC Mannkind Corp Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$1.14 - $2.25 $52,211 - $103,050
-45,800 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$1.02 - $2.05 $41,208 - $82,820
-40,400 Reduced 46.87%
45,800 $49,000
Q3 2018

Nov 13, 2018
SELL
$1.01 - $2.19 $7,070 - $15,330
-7,000 Reduced 7.51%
86,200 $158,000
Q2 2018

Aug 14, 2018
BUY
$1.59 - $2.38 $148,188 - $221,816
93,200 New
93,200 $177,000

Others Institutions Holding MNKD

# of Institutions
245
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.69B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email